Powerful alliances on Capitol Hill
Sanders is advocating for an insulin price cap bill that curiously shields drug manufacturers from shouldering the cost. He’s also backing a bill that would curtail pharmacy benefit managers (PBMs), the third-party companies that negotiate for lower costs for individual consumers.
Big Pharma likes to transfer the blame for skyrocketing drug costs to PBMs, which is why the industry supports the bill. If passed, the legislation will allocate more power to PhRMA over the healthcare industry. It will also increase the profits of pharmaceutical companies. Unfortunately, the legislation may pass due to staunch support from Sanders, and other progressive Democrats.
While the drug industry’s new woke image has created strong alliances with progressive Democrats, hard-working Americans should not be fooled. Big Pharma’s foremost goal is to maximize profits by any means necessary.
In 2022, revenues for the pharmaceutical industry, worldwide, totaled $1.48 trillion, an amount that has been steadily increasing for many years. Of the worldwide pharmaceutical market, the United States has the largest share at 42.6%, approximately 600% larger than China, the country that ranks second on the list.
Obviously, in recent years, Big Pharma has become more powerful and is raking in more money. This success has been achieved through powerful alliances on Capitol Hill, especially with progressive Democrats. Therefore, it is essential that congressional Republicans stand firm against this costly power play.
It is corporate cronyism at its worst and has gone on far too long on Capitol Hill.